Notice to Readers
Enterobacter cloacae Bloodstream Infections Associated with
Contaminated Prefilled Saline Syringes -- California, November 1998
During November 2-5, 1998, 11 children who received outpatient
therapy from the hematology/oncology service at a hospital in
California developed sepsis; 10 had Enterobacter cloacae-positive
blood cultures. All patients had received intravascular catheter
flushes using prefilled saline syringes (CAPS, Braun-McGaw,
Detroit, Michigan). Culture of an unopened prefilled syringe grew
E. cloacae with identical biochemical profiles to that of the
patients. On November 9, the manufacturer initiated a recall of the
syringes.
Clinicians detecting episodes of sepsis or bloodstream
infection associated with prefilled saline syringes are requested
to report these episodes to CDC's Hospital Infections Program,
National Center for Infectious Diseases, telephone (404) 639-6413;
fax (404) 639-6459; and to MedWatch, the Food and Drug
Administration's Medical Products Reporting Program, telephone
(800) 332-1088; fax (800) 332-0178; address: MedWatch, 5600 Fishers
Lane, Rockville MD 20852-9787; or on the World-Wide Web,
http://www.fda.gov/medwatch.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
